Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

ChromaDex Q2 EPS $(0.03) Beats $(0.04) Estimate, Sales $20.32M Beat $19.19M Estimate

Author: Benzinga Newsdesk | August 09, 2023 04:50pm
ChromaDex (NASDAQ:CDXC) reported quarterly losses of $(0.03) per share which beat the analyst consensus estimate of $(0.04) by 25 percent. This is a 66.67 percent increase over losses of $(0.09) per share from the same period last year. The company reported quarterly sales of $20.32 million which beat the analyst consensus estimate of $19.19 million by 5.90 percent. This is a 21.46 percent increase over sales of $16.73 million the same period last year.

Posted In: CDXC


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist